Bollard Group’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-413
Closed -$30K 444
2020
Q2
$30K Buy
+413
New +$30K ﹤0.01% 386